The GEMINI-NSCLC study is a research project for people with Non-Small Cell Lung Cancer (NSCLC). NSCLC is a type of lung cancer. This study is non-interventional, meaning it won't change your current treatment. Instead, it collects health information, including blood samples, to understand how lung cancer changes over time. The aim is to see if a blood test called ctDNA can help predict if the cancer will come back or how it will respond to treatment.

• Eligibility: You must be 18 or older, have NSCLC, and be willing to provide blood and tumor samples.
• Participation: You will continue with your normal treatment and attend regular visits for blood collection.
• Exclusions: You cannot have other types of cancer or refuse blood sample collection.

This study may help improve future lung cancer treatments by providing more information about how the disease changes. If you meet the criteria and agree to participate, your involvement could make a difference in understanding and treating NSCLC more effectively.